IL106505A0 - Isolation and cloning of a protein with tyrosine-phosphatase activity - Google Patents

Isolation and cloning of a protein with tyrosine-phosphatase activity

Info

Publication number
IL106505A0
IL106505A0 IL106505A IL10650593A IL106505A0 IL 106505 A0 IL106505 A0 IL 106505A0 IL 106505 A IL106505 A IL 106505A IL 10650593 A IL10650593 A IL 10650593A IL 106505 A0 IL106505 A0 IL 106505A0
Authority
IL
Israel
Prior art keywords
tyrosine
cloning
isolation
protein
phosphatase activity
Prior art date
Application number
IL106505A
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL106505A0 publication Critical patent/IL106505A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
IL106505A 1992-07-31 1993-07-28 Isolation and cloning of a protein with tyrosine-phosphatase activity IL106505A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216328A GB9216328D0 (en) 1992-07-31 1992-07-31 Isolation and cloning of a protein with tyrosine-phosphatase activity

Publications (1)

Publication Number Publication Date
IL106505A0 true IL106505A0 (en) 1993-11-15

Family

ID=10719632

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106505A IL106505A0 (en) 1992-07-31 1993-07-28 Isolation and cloning of a protein with tyrosine-phosphatase activity

Country Status (8)

Country Link
EP (1) EP0652959A1 (en)
CN (1) CN1082110A (en)
AU (1) AU4704793A (en)
GB (1) GB9216328D0 (en)
IL (1) IL106505A0 (en)
MX (1) MX9304580A (en)
WO (1) WO1994003610A2 (en)
ZA (1) ZA935483B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032087A1 (en) 1990-07-11 2005-02-10 New York University Novel receptor-type phosphotyrosine phosphatase-alpha
US5604094A (en) * 1990-07-11 1997-02-18 New York University Receptor-type phosphotyrosine phosphatase-β
US6682905B1 (en) 1990-07-11 2004-01-27 New York University Receptor-type phosphotyrosine phosphatase-alpha
ATE236983T1 (en) 1994-05-03 2003-04-15 Cold Spring Harbor Lab PROTEIN TYROSINE PHOSPHATASES STIMULATED BY CELL DENSITY
EP0929683A1 (en) * 1996-03-06 1999-07-21 ZymoGenetics, Inc. DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE
US6399326B1 (en) 1996-07-02 2002-06-04 President And Fellows Of Harvard College Nucleic acids encoding neural/pancreatic receptor tyrosine phosphatase
US6060298A (en) * 1996-12-20 2000-05-09 Novo Nordisk A/S Peniophora phytase
ES2150795T3 (en) * 1996-12-20 2000-12-01 Novo Nordisk As PHYTASE OF PENIOPHORA.
WO2000053801A1 (en) * 1999-03-08 2000-09-14 Merck Frosst Canada & Co. Intact cell assay for protein tyrosine phosphatases
JP6311125B2 (en) * 2014-11-26 2018-04-18 パナソニックＩｐマネジメント株式会社 Washing machine
CN108823180A (en) * 2018-06-29 2018-11-16 云南大学 Make the dephosphorylized albumen of protein kinase B specific site and its nucleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0538401B1 (en) * 1990-07-11 1999-07-28 New York University Novel receptor-type phosphotyrosine phosphatase

Also Published As

Publication number Publication date
WO1994003610A2 (en) 1994-02-17
ZA935483B (en) 1994-02-28
WO1994003610A3 (en) 1994-03-31
EP0652959A1 (en) 1995-05-17
CN1082110A (en) 1994-02-16
MX9304580A (en) 1994-02-28
AU4704793A (en) 1994-03-03
GB9216328D0 (en) 1992-09-16

Similar Documents

Publication Publication Date Title
ZA939416B (en) Modified lipolytic enzymes and their use
HU9301510D0 (en) Inhibition of interaction of protein causing cell adhession and carbonhydrate
AU673703B2 (en) Injector and use of the same
GB9300213D0 (en) Wrist and hand support
AU4840293A (en) Cloning and expression of pur protein
ZA932362B (en) Cloning expression and uses of a novel secreted protein F-spondin
IL108175A0 (en) Cloning and expression of xylanase B
GB9413938D0 (en) Activity toy and walker
GB8924907D0 (en) Nozzle assembly and method of providing same
ZA939415B (en) Modified lipolytic enzymes and their use
AU680816B2 (en) Cloning and expression of DNA encoding a ripening form of a polypeptide having phamnogalacturonase activity
GB9216328D0 (en) Isolation and cloning of a protein with tyrosine-phosphatase activity
AU590640B2 (en) Dementia-improving and therapeutic agents
HU9402361D0 (en) New makrolides and use of them
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
EP0565626A4 (en) Fusions of a viral protein and a destructive enzyme
EP0726964A4 (en) Isolation and composition of novel glycosidases
SG52295A1 (en) Antimigraine cyclobutenedione derivatives of indolyalkyl-pyridinyl and pyrimidinylpiperazines
PL304896A1 (en) Cloning and expression of exo-polygalaktrurinase of aspergillus origin
GB9216582D0 (en) Determination of enzyme activity
GB9212261D0 (en) Enzyme cloning
ZA946201B (en) Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
GB9408466D0 (en) Cloning and functional expression of neurotoxins
GB8408704D0 (en) Explosive-abrasive surfacing and spraying
LTIP1527A (en) Cloning and expression of microbial phytase